Short communication · 28 Feb 2025
Byline
P. Davis
Articles whose byline reads P. Davis, printed most often as Paul J Davis, Paul J. Davis, Davis P, Patricia Davis and Paul B. Davis. Different authors can share a byline.
- Articles
- 46
- Latest year
- 2025
Articles
Newest first. Showing 1–25 of 46 articles.
Article · 29 Jan 2025
Evaluating Tinnitus Distress from the Perspective of Significant Others Using a Novel Questionnaire
Commentary · 27 Sep 2023
Exploring Liquid Diets: Rapid Weight Loss, Detox, and Health Benefits
Article · 13 Aug 2020
A thyroid hormone-derived anticancer agent P-bi-TAT, regulates cancer cell respiratory enzyme gene expression from a cell surface receptor
Editorial · 28 Jul 2020
Cell surface receptor for thyroid hormone analogues on integrin in tumor cells regulates expression of cancer cell genes relevant to the cell cycle apoptosis chemoresistance and angiogenesis_ Paul J Davis_ Albany Medical College_ USA
Conference proceeding · Dec 2019
Awards at Cancer Biology, Immuno Oncology and Drug Discovery 2020 Conference
Conference abstract · Dec 2019
Young Researchers Forum: Young Scientist Awards for CBIOD 2020
Conference abstract · 25 Mar 2019
Induction of expression of pd-l1 by thyroid hormone interferes with resveratrol-induced antiproliferation in cancer cells
Conference abstract · 25 Mar 2019
Systematic searching for small molecule ligands of integrin αvβ3
Conference abstract · 25 Mar 2019
A cell surface receptor for thyroid hormone analogues on integrin αvβ3 in tumor cells regulates expression of cancer cell genes relevant to the cell cycle apoptosis chemoresistance and angiogenesis
Conference abstract · 25 Mar 2019
Systematic searching for small molecule ligands of integrin αvβ3
Conference abstract · 25 Mar 2019
A cell surface receptor for thyroid hormone analogues on integrin αvβ3 in tumor cells regulates expression of cancer cell genes relevant to the cell cycle apoptosis chemoresistance and angiogenesis
Conference proceeding · 2019
Market Analysis of Biology, Immuno Oncology and Drug Discovery Conference
Other · 2019
2020 Announcement of Women cancer and Nursing care Conference
Editorial · 3 Sep 2018
Stem Cell Research 2017 : Nano-diamino-tetrac (NDAT; Nanotetrac) acts at its target on integrin αvβ3 in human glioblastoma xenografts to induce necrosis via. anti-angiogenesis and apoptosis_ Paul J Davis_ Albany College of Pharmacy and Health Sciences, USA
Conference abstract · 19 Mar 2018
Possible clinical significance of reverse T3 (rT3) and L-thyroxine (T4) levels in cancer-related nonthyroidal illness syndrome (NTIS)
Conference abstract · 19 Mar 2018
Possible clinical significance of reverse T3 (rT3) and L-thyroxine (T4) levels in cancer-related nonthyroidal illness syndrome (NTIS)
Conference abstract · 26 Jun 2017
Cancer stem cells in isocitrate dehydrogenase wild type glioblastoma express components of the reninangiotensin system and cathepsins B, D and G
Conference abstract · 20 Mar 2017
PD-L1 and PD-1 gene expression are both stimulated by thyroid hormone in cancer cells
Conference abstract · 20 Mar 2017
Nano-diamino-tetrac (NDAT; Nanotetrac) acts at its target on integrin αvβ3 in human glioblastoma xenografts to induce necrosis via. anti-angiogenesis and apoptosis
Conference abstract · 20 Mar 2017
PD-L1 and PD-1 gene expression are both stimulated by thyroid hormone in cancer cells
Conference abstract · 20 Mar 2017
Nano-diamino-tetrac (NDAT; Nanotetrac) acts at its target on integrin v3 in human glioblastoma xenografts to induce necrosis via anti-angiogenesis and apoptosis
Conference abstract · 27 Jun 2016
Modulation of angiogenesis and anti-angiogenesis at targets on integrin v3
Conference abstract · 27 Jun 2016
Targeted delivery of generic chemotherapeutic agents to solid tumors via systemic nanotetrac (Nano-diamino-tetrac)
Conference abstract · 27 Jun 2016

